Miller-Rich Nancy's Form 4 filing
Aldeyra Therapeutics, Inc. (ALDX) · filed Oct 21, 2024
- Accession no.
- 0000950170-24-116048
- Filed
- Oct 21, 2024
- Trade date
- May 3, 2021-Apr 12, 2023
- Filing delay
- 1,267 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.4K. It was filed 1267 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller-Rich NancyCIK 0001735084 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2021 | Common Stock | PPurchaseAcquired | +413 | $12.81 | +$5,290.53 | 413 | Direct | |
| Apr 12, 2023 | Common Stock | PPurchaseAcquired | +509 | $10.13 | +$5,156.17 | 922 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.